Market News

Evercore ISI Group analyst Mark Mahaney maintains Lyft (NASDAQ:LYFT) with a In-Line and lowers the price target from $21 to $20.

Advanced Micro Devices' 35% selloff created a nice buying opportunity, as its Data Center segment has doubled in just one year. Read more on AMD stock...

Evercore ISI Group analyst Glenn Schorr maintains Invesco (NYSE:IVZ) with a In-Line and lowers the price target from $34 to $33.

Marathon Petroleum clears all eight of Louis Navellier’s Little Book growth criteria, with explosive growth, very strong cash flow, and a cheap P/E.

Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $150 to $135.

Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers the price target from $150 to $140.

Evercore ISI Group analyst Stephen Kim maintains Installed Building Prods (NYSE:IBP) with a In-Line and lowers the price target from $222 to $215.

RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pha...

IRVING, Texas, November 06, 2026--Fluor Corporation (NYSE: FLR) announced financial results for its third quarter ended September 30, 2026.

Wells Fargo analyst Nathan Treybeck maintains Solventum (NYSE:SOLV) with a Equal-Weight and raises the price target from $89 to $95.

Calumet (NASDAQ:CLMT) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provi...

Evercore ISI Group analyst Michael DiFiore maintains Halozyme Therapeutics (NASDAQ:HALO) with a Outperform and raises the price target from $123 to...

Was the timing good for this member of Congress who sold shares of a semiconductor stock and bought shares in another one?

Rising radar volume and robotics expansion drive indie past Q3 targets, unlocking critical operating leverage for a future profit turn.

(Updates with Novartis' response in the fourth and fifth paragraphs and latest stock moves in the si

Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $20 to $25.

Chesapeake Utilities (NYSE:CPK) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has ...

Oklo stock rises after Q3 revenue beats estimates, Aurora reactor construction advances and a new manufacturing deal supports expansion.